Join
Live feed
·
INSIDERFilingvia Quantisnow
Hepion Pharmaceuticals Inc. logo

SEC Form 4: Peter Wijngaard bought $22,000 worth of Common Stock (10,000 units at $2.20), increasing ownership by 50% to 30,000 units

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track HEPA (Hepion Pharmaceuticals Inc.) and more on Quantisnow.